Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Receivables (2022 - 2025)

GE HealthCare Technologies' Receivables history spans 4 years, with the latest figure at $4.3 billion for Q4 2025.

  • For the quarter ending Q4 2025, Receivables rose 3.35% year-over-year to $4.3 billion, compared with a TTM value of $4.3 billion through Dec 2025, up 3.35%, and an annual FY2025 reading of $4.3 billion, up 3.35% over the prior year.
  • Receivables for Q4 2025 was $4.3 billion at GE HealthCare Technologies, up from $4.1 billion in the prior quarter.
  • The five-year high for Receivables was $4.3 billion in Q4 2025, with the low at $283.0 million in Q2 2024.
  • Average Receivables over 4 years is $3.7 billion, with a median of $4.0 billion recorded in 2023.
  • Year-over-year, Receivables plummeted 92.95% in 2024 and then surged 1275.97% in 2025.
  • Tracing GEHC's Receivables over 4 years: stood at $3.6 billion in 2022, then grew by 15.58% to $4.1 billion in 2023, then grew by 0.73% to $4.2 billion in 2024, then grew by 3.35% to $4.3 billion in 2025.
  • Per Business Quant, the three most recent readings for GEHC's Receivables are $4.3 billion (Q4 2025), $4.1 billion (Q3 2025), and $3.9 billion (Q2 2025).